Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC3144634/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC3144634/. The analysis below is for the second page.

Title[redir]:
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 - PMC
Description:
The 12th St Gallen International Breast Cancer Conference (2011) Expert Panel adopted a new approach to the classification of patients for therapeutic purposes based on the recognition of intrinsic biological subtypes within the breast cancer ...

Matching Content Categories {📚}

  • Health & Fitness
  • Education
  • Science

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 6,398,976 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We can't tell how the site generates income.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Ncbi.nlm.nih.gov might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

cancer, doi, breast, google, scholar, pubmed, patients, therapy, consultant, speakers, bureau, chemotherapy, panel, pmc, trial, adjuvant, research, travel, disease, article, treatment, free, endocrine, oncol, trastuzumab, subtypes, luminal, neoadjuvant, center, oncology, clin, negative, university, risk, clinical, positive, study, roche, jco, women, department, results, estrogen, novartis, gene, receptor, tumor, benefit, gsk, usa,

Topics {✒️}

oestrogen-receptor-positive breast cancer oestrogen-receptor-poor breast cancer progestin-driven mammary cancer sentinel-lymph-node resection compared genetic/familial high-risk assessment improve disease-free survival conventional axillary-lymph-node dissection hormone receptor-positive disease post-mastectomy radiation therapy intergroup trial c9741/cancer early-stage breast cancer dana-farber cancer institute superior disease-free survival estrogen receptor-positive disease pmc beta search node-positive breast cancer disease-free survival benefit low-volume metastatic disease helios klinikum berlin-buch estrogen receptor-negative disease breast-conserving approaches pioneered 8-year disease-free survival node-negative breast cancer low-grade low-risk dcis her2-positive breast cancer triple-negative breast cancer clinically node-negative axilla clinically node-negative disease parallel her2-negative cohort amplified erb-b2 overexpression er-positive breast cancer comparing radical mastectomy disease-free survival event-free survival endocrine-responsive breast cancer publisher site pdf clinically node-negative patients single-agent parp inhibitors 12th international conference rank ligand antagonists brca1-positive breast cancers estrogen receptor-positive highly endocrine-responsive disease human breast cancer start trialists' group single-agent chemotherapy compared advanced breast cancer united states government metastatic breast cancer male breast cancer

Questions {❓}

  • Autologous fat transplantation in patients with breast cancer: “silencing” or “fueling” cancer recurrence?
  • Bevacizumab for advanced breast cancer: all tied up with a RIBBON?
  • Is gene array testing to be considered routine now?
  • Is there a case for anti-HER2 treatment without chemotherapy?

Social Networks {👍}(6)

External Links {🔗}(186)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • jQuery
  • jQuery module (jquery-3.6.0)

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

3.77s.